AlphaStocks

AZN vs COR

ASTRAZENECA PLC vs Cencora, Inc. — Side-by-Side Stock Comparison

AZN

ASTRAZENECA PLC

8.4

Strong Buy

$184.80

COR

Cencora, Inc.

4.4

Weak

$252.67

AZN vs COR: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 8.4/10 while Cencora, Inc. (COR) scores 4.4/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy. On a P/E basis, ASTRAZENECA PLC trades at 28.2x, making it the more attractively priced of the two. ASTRAZENECA PLC offers more upside to its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricAZNCOR
Scores & Fundamentals
Composite Score8.4/104.4/10
RatingStrong BuyWeak
Price$184.80$252.67
P/E Ratio28.231.7
ROE21.9%89.1%
Market Cap$289B$49B
Fair Value$192.63$197.12
Dividend Yield1.7%0.9%
Sector Rank#2 of 1126#739 of 1126
Model Verdicts
PiotroskiStrongAttractive
BuffettStrongStrong
GrahamCautionNeutral
LynchNeutralNeutral
GreenblattNeutralCaution
View full AZNanalysis →View full CORanalysis →
Compare any two stocks →

AZN vs COR: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) and Cencora, Inc. (COR) are among the most compared stocks in the Health Care sector. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to COR's 4.4/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer